eISSN: 2354-0265
ISSN: 2353-6942
Health Problems of Civilization Physical activity: diseases and issues recognized by the WHO
Bieżący numer Archiwum Online first O czasopiśmie Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
Poleć ten artykuł:
Udostępnij:
List do Redakcji

UKRYTE ZAGROŻENIA ZWIĄZANE Z KSYLITOLEM I ERYTRYTOLEM: WEZWANIE DO DALSZYCH BADAŃ

Agnieszka Głuszczyk
1
,
Jakub Igor Plizga
1

  1. 4th Military Clinical Hospital, Wrocław, Poland
Health Prob Civil.
Data publikacji online: 2024/07/04
Plik artykułu:
- Głuszczyk et al.pdf  [0.25 MB]
Pobierz cytowanie
 
Metryki PlumX:
 
1. Reimisz P. Use of low-calorie sweeteners in treating obesity. Health Prob Civil. 2023; 17(2): 145-160. https://doi.org/10.5114/hpc.2023.128034
2. Witkowski M, Nemet I, Li XS, Wilcox J, Ferrell M, Alamri H, et al. Xylitol is prothrombotic and associated with cardiovascular risk. European Heart Journal. Forthcoming 2024. https://doi.org/10.1093/eurheartj/ehae244
3. Witkowski M, Nemet I, Alamri H, Wilcox J, Gupta N, Nimer N, et al. The artificial sweetener erythritol and cardiovascular event risk. Nature Medicine. 2023; 29(3): 710-718. https://doi.org/10.1038/s41591-023-02223-9
4. Khafagy R, Paterson AD, Dash S. Erythritol as a potential causal contributor to cardiometabolic disease: a mendelian randomization study. Diabetes. 2024; 73(2): 325-331. https://doi.org/10.2337/db23-0330
Copyright: © 2024 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

© 2024 Termedia Sp. z o.o.
Developed by Bentus.